English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1826]
News [2764]
Articles [207]
Editorials [1]
Conferences [136]
elearning [13]
Personalising paediatric cancer care with gene networks and AI
Personalising paediatric cancer care with gene networks and AI
Targeting sleeping tumour cells
Targeting sleeping tumour cells
Dynamin 1-mediated endocytic recycling of glycosylated N-cadherin sustains the plastic mesenchymal state to promote ovarian cancer metastasis
Dynamin 1-mediated endocytic recycling of glycosylated N-cadherin sustains the plastic mesenchymal state to...
Reinvigorating exhausted T cells in cancer and chronic viral infections cells. However, in chronic viral infection and cancer, the killer cells often lapse into “exhausted”  CD8+ T cells that no longer can stem disease
Reinvigorating exhausted T cells in cancer and chronic viral infections cells. However, in chronic viral infection...
Novel radioimmunotherapy eradicates cancer stem cells in ovarian cancer model
Novel radioimmunotherapy eradicates cancer stem cells in ovarian cancer model
Immunotherapy for leukaemia may affect the bone marrow environment, cancer researchers find
Immunotherapy for leukaemia may affect the bone marrow environment, cancer researchers find
Cabozantinib approved in the EU for previously treated advanced neuroendocrine tumours
Cabozantinib approved in the EU for previously treated advanced neuroendocrine tumours
Belantamab mafodotin combinations approved in EU for treatment of relapsed/refractory multiple myeloma
Belantamab mafodotin combinations approved in EU for treatment of relapsed/refractory multiple myeloma
‘Powerful new approach’: New drug combination strategy shows promise against hard-to-treat cancers
‘Powerful new approach’: New drug combination strategy shows promise against hard-to-treat cancers
Less is more: Low-dose olanzapine curbs chemo-induced nausea without the sedation
Less is more: Low-dose olanzapine curbs chemo-induced nausea without the sedation
<12345...277>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top